Tiger, if history is any indication, you will buy this at $1.50 and sell at $1.53. I'm still laughing at you! You are one of the biggest liars on this board. One minute you are long the next you are bashing. Why don't you take your .03 profit before short term capital gains tax and leave! You are no use to this board. You, my friend, are a loser!
Assuming we maintain our best in class results (big assumption, I know), I think $20.00 per share is too low for 2016. By then we could have 3-4 vaccines in phase 3 or beyond and a whole slew in phase 2. We may even have a vaccine approved if afforded breakthrough designation (e.g. HIV). A 3.8 billion dollar market cap just doesn't seem enough. At that point I'd imagine we would have a market cap upwards of 6 billion, and I still think that would be conservative.
I'm not sure what the bashers say to that, but a large shareholder from the .50's says no way in hell to $20 for Inovio...we can get there on on our own in 1-2 years..if they offered that in 1-2 years though can't say I wouldn't be tempted to vote yes!
Sentiment: Strong Buy